KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Minority Interest (2016 - 2025)

Historic Minority Interest for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $48.0 million.

  • Bristol Myers Squibb's Minority Interest fell 1724.14% to $48.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.0 million, marking a year-over-year decrease of 1724.14%. This contributed to the annual value of $53.0 million for FY2024, which is 363.64% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Minority Interest is $48.0 million, which was down 1724.14% from $54.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Minority Interest's 5-year high stood at $71.0 million during Q3 2021, with a 5-year trough of $48.0 million in Q3 2025.
  • Its 5-year average for Minority Interest is $59.6 million, with a median of $59.0 million in 2025.
  • Per our database at Business Quant, Bristol Myers Squibb's Minority Interest skyrocketed by 303.03% in 2021 and then tumbled by 1724.14% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Minority Interest stood at $60.0 million in 2021, then decreased by 5.0% to $57.0 million in 2022, then decreased by 3.51% to $55.0 million in 2023, then decreased by 3.64% to $53.0 million in 2024, then decreased by 9.43% to $48.0 million in 2025.
  • Its Minority Interest stands at $48.0 million for Q3 2025, versus $54.0 million for Q2 2025 and $59.0 million for Q1 2025.